FierceBiotech: Werewolf Therapeutics uncloaks with $56M and shape-shifting cancer meds

It’s a full moon for Werewolf Therapeutics as the company comes out of stealth with $56 million and an approach it believes can cut through the toxic effects that have limited the use of certain cancer-killing agents.

Read the full story


By Amirah Al Idrus